Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Natural Killer Cell Malignancies
Total 0 results
Nothing found
Sponsors and Collaborators
Microsoft Corporation
Psoriasis Association
Dong-A Pharmaceutical Co., Ltd.
The Marfan Foundation
Bayfront Health St Petersburg
Stefano Malinverni, MD
Duke Clinical and Translational Science Institute (CTSI), part of the NIH Clinical and Translational Science Awards (CTSA)
Natrol
Luigi Canullo
Aider Perpignan : Dr Ahmed RACHI
Deutsche Klinik Bad Münder
Else Kröner-Fresenius Stiftung, Bad Homburg, Germany
Skidmore College
Villarreal CF
L. Eugene Arnold
Avextra Pharma GmbH
Wellcome Leap Organization
CellOxess LLC
Stemina Biomarker Discovery, Inc.
Sligo General Hospital
View Full List
Medical Conditions
Epidermolysis Bullosa Simplex, Generalized
Erector Spinae Plane Block
STRETCHING
Perioperative Sedation
Stage II Adult Liver Cancer
Epithelial Hyperplasia Without Atypia
Gastroparesis Due to Diabetes Mellitus Type I
Dental Carie; Orthodontics
Double Lumen Endotracheal Tube
ACL Reconstruction
Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7
Non Throwing Shoulders
Cystoscope
Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7
Myocardial Bridge of Coronary Artery
Wound Infection or Endometritis Post Cesarean Section
Colonic Diseases
Acute Tubulo-Interstitial Nephritis
Left Ventricular (LV) Systolic Dysfunction
Primary Renal Transplant
View Full List
Drug Interventions
Eribulin Mesylate
YY-20394 treatment
BeneFIX
Paliperidone ER
Pertuzumab IV
PEP005 (Ingenol mebutat Gel, 0.05 %)
36 Weeks Methylprednisolone
Resin infiltration
PZA sensitivity guided ultra-short all Oral Regimen
Temozolomide
Esomeprazole
Nogapendekin Alfa
Tobramycin
Brivanib
Hydroxychloroquine
0.03% DSC127 topical gel
Standard of care
INCB009471
Paricalcitol
Keytruda
View Full List
CROs by country
Contract Research Organizations in Argentina
Contract Research Organizations in Australia
Contract Research Organizations in Bangladesh
Contract Research Organizations in Benin
Contract Research Organizations in Hungary
Contract Research Organizations in Jamaica
Contract Research Organizations in Latvia
Contract Research Organizations in Mauritania
Contract Research Organizations in Mongolia
Contract Research Organizations in Poland
Contract Research Organizations in Slovenia
Contract Research Organizations in South Korea
Contract Research Organizations in Sweden
CRO list by country
CROs in Nigeria
SGS
Bispharm Clinical
ACROSS Global
Celero
54gene’s Clinical Programs Group (CPG)
All CROs in Nigeria
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe